Online ISSN: 2515-8260

Keywords : Inflammatory Markers


STUDY OF COVID19 OBSTETRIC CASES ADMITTED IN MATERNAL INTENSIVE CARE UNIT AND FETOMATERNAL OUTCOME

Prof.Dr.Sangeeta Shah, Dr.Kora Sravanthi, Dr.Mrinalini Mitra, Dr.G.Sai Maheswari

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 4414-4421

OBJECTIVES

Study of covid 19 obstetric cases admitted in maternal intensive care unit.
To study the fetomaternal outcome of covid 19 pregnant women

METHODS

This was an observational study carried out in the department of Obstetrics and Gynecology at Gandhi hospital, a tertiary care centre in Telangana. 100 women were taken into the study based on COVID19 test status.

RESULTS
Among 100 covid patients who were admitted into maternal intensive care unit, were in the range of 17 to 35years. Most (64%) of the patients were primigravida and majority (64%) of them were admitted in third trimester. 36 patients were without any co-morbidity, 38 patients belong to hypertensive disorders, 12 patients had anemia. High sugars and heart disease complicating pregnancy cases were also admitted.Inflammatory markers were raised in covid patients. All the patients had elevated CRP. Serum ferritin was raised in 53patients, LDH was raised in 46patients and 24patients were having raised D-Dimer.70% patients were managed with NIV.38% patient’s babies were admitted into NICU due to respiratory distress, low birth weight and seizures. Among 100 patients, 62% patients were discharged with good outcome and 38% patients were died.
CONCLUSION
Covid 19 during pregnancy may happen without identifiable risk factors. Although the risk of poor maternal and perinatal outcome increases when intensive care unit admission is required, adequate respiratory support adapted to the clinical status and interdisciplinary management of critical cases may not only lead to maternal recovery, but also an improvement in neonatal outcomes.

" A cross-sectional observational Study to assess the severity of coronavirus disease 2019 according to Clinical value of immune inflammatory markers"

Dr. Sarika Rawat Dr. Sunil Bajoliya Dr. Sachin Kumbhare Dr Roshan Mandloi Dr. Ranjeet Badole

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 6, Pages 955-961

Title-" A cross-sectional observational  Study to assess the severity of coronavirus disease 2019 according to Clinical value of immune  inflammatory markers"
Background: In Wuhan, China, since December 2019, a new strain of pneumonia has appeared and spread quickly over the world. The World Health Organization determined that a separate strain of coronavirus, designated COVID-19, caused this pneumonia (WHO). This unique coronavirus was identified as acute respiratory syndrome coronavirus 2 based on phylogeny, taxonomy, and accepted practise (SARS-COV2).
Objective: a cross-sectional observational study to show the co-relation between inflammatory markers and the severity of disease
Materials and Methods: a total of 250 patients were selected who are microbiologically covid positive and ready to give consent were included in the study. There basic test will be done.
Result- There is preponderance of male gender among the patients 147 were male 103 were female. The mean age of participant is 43 ±2.825 (±6.57%)65 patient were immediately required the either oxygen or mechanical ventilation,among all this 26 patient were died. Among this entire 65 patient, 21 patients have raise CRP level,14 have raised IL -6 Level among them all 26 were have raised D-Dimer .
Conclusion- Our study showed that high level of D-Dimer, IL-6 and CRP was independent risk factors for assessing the severity of COVID-19. IL-6 played a determiningrole in the severity of SARS-COV2 and had a potential value for monitoring the process of severe cases.

To assess the severity of COVID-19 in relation toclinical value of immune inflammatory markers: An observational study

Dr. Preety Motiyani, Dr. RS Meena, Dr. Dileep Dandotiya, Dr. Mamta Meena, Dr. Jitendra Rai

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 657-662

Background: Since December 2019, an novel type of pneumonia emergedin
Wuhan,China,and rapidly transmitted to wholeglobe. This pneumonia was verified to
be caused by a different strain coronavirus and named as coronavirus disease
2019(COVID-19) bythe World Health Organization (WHO). Based on
phylogeny,taxonomy and established practice, this novel coronavirus was designated
as severe acute respiratory syndrome coronavirus2 (SARS-COV2).
Objectives: To show the co-relation between inflammatory markers and the severity of
COVID-19 disease

Haematological parameters in type 2 diabetes mellitus, controlled and uncontrolled

Akhouri Sukrit Prakash

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 10078-10084

Aims: To compare HbA1c levels with inflammatory markers that include a neutrophilto-
lymphocyte ratio (NLR) and monocyteto-lymphocyte ratio (MLR) in controlled and
uncontrolled diabetics.
Materials and methods: Two hundred type 2 diabetes mellitus (T2DM) patients were
separated into two groups of managed (HbA1c 7%) diabetics. HbA1c (glycated
haemoglobin) levels, leukocyte count (WBC), haemoglobin (Hb), hematocrit (Hct), red
blood cell distribution width (RDW), neutrophils, lymphocytes, and monocytes were all
measured using recent laboratory data. The laboratory results were used to determine
the NLR and MLR.
Results:Controlled diabetics had a mean age of 58.30 years, while uncontrolled diabetics
had a mean age of 55.62 years. The mean NLR in diabetics with and without diabetes
was 2.61 and 4.88, respectively. The distinction was discovered to be statistically
significant (p < 0.05). The mean MLR in diabetics with and without diabetes was 0.2
and 0.24, respectively, however the difference was not statistically significant (p > 0.05).
The data showed a modest positive connection between HbA1c levels and the
haematological indices, but it was statistically insignificant.
Conclusion: The study found a substantial difference in NLR between diabetics who
were well-controlled and those who were not. Although only a slight positive connection
was detected between glycated Hb levels and the haematological indices, the results
revealed a substantial difference in NLR between the two groups. This demonstrates
that these ratios have the potential to be used as inflammatory indicators in T2DM.

Inflammatory markers and lipid profile based on age in asymptomatic individuals with or without family history of type 2 diabetes mellitus

Dr. Shreya Nigoskar, Bonala Sharat Babu

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 1, Pages 1219-1224

Introduction: Although there was a weak positive link between inflammatory indicators and
serum lipid levels, assessing both of these parameters combined may aid in the early
detection and treatment of people who are at high risk for metabolic disorders like type 2
diabetes mellitus and other cardio vascular diseases.
Materials and Methods: This experiment was carried out at the Department of Biochemistry
research lab in India. The sample size was determined to be N=100 based on a 0.56
connection between visceral fat composition and oxidative stress and inflammation. The
study included students and apparently healthy cases between the ages of 18 and 30 who
followed DM patients in (n = 50). Individuals taking any medications for a health condition
that precludes them from performing sub-maximal exercise, as well as those who participate
in regular physical activity, yoga, or other biofeedback, were excluded from the study. Age
and gender matched ostensibly healthy persons with no family history of diabetes were
recruited for the control group (n = 50).
Results: Significant difference was noted in the inflammatory markers & the lipid profile
parameters except for the HDL. In individual with type 2 diabetes, worsening dyslipidemia
and inflammation over time raises concerns about the early onset of atherosclerosis. In the
absence of glycemic control, insulin treatment is of poor effect. Efforts to improve glycemic
control are required.
Conclusion:Lipid profile of an individual is associated to obesity, inflammation, vascular
function, and diabetes. Appropriate lifestyle adjustments may be performed to lower the
inflammatory markers and metabolic disorders. A greater understanding of the causes of
inflammatory markers and lipid profile aid in the development of specialized therapeutic
approaches for treatment of type 2 diabetes mellitus.

Assessment and Comparison of Ghrelin and Chemerin Levels in Gingival Crevicular Fluid and Serum as Predictive Biomarkers in Aggressive Periodontitis Patients: A Study Protocol

Dr. Pavan , Bajaj; Dr. Prasad V. , Dhadse; Dr. Vidya Baliga; Dr. Priyanka Jaiswal

European Journal of Molecular & Clinical Medicine, 2020, Volume 7, Issue 2, Pages 2027-2033

Abstract: Background: Ghrelin is a recently described peptide hormone that is secreted
predominantly by the stomach. It induces appetite and thereby controls food intake and energy
balance. It has been also observed modulatory effects on the immune system and bone
metabolism. Chemerin binds to an orphan G coupled receptor which modulates the innate
immune system and chemotaxis of immature dendritic cells and macrophages. Objective:
Comparative evaluation of GCF & Serum “levels of Ghrelin and Chemerin” as the
(Predictive) biomarkers of inflammation in aggressive periodontitis. Methodology: Total 80
samples will be included and divided into two groups. Group I includes 40 GCF samples from
40 subjects with aggressive and Group II includes 40 Serum samples from 40 subjects with
aggressive periodontitis group. The GCF will be collected from the site with deepest probing
depth. Gingival index, probing pocket depth and clinical attachment level will be measured
one day before GCF collection to avoid stimulation of the sample and its contamination with
blood. The Ghrelin and Chemerin levels in GCF and serum samples will be measured using
an ELISA kit. Expected Result: